CORTEVA INC (CTVA) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CTVA • US22052L1044

75.12 USD
+0.08 (+0.11%)
At close: Feb 4, 2026
75.12 USD
0 (0%)
After Hours: 2/4/2026, 7:00:00 PM
Fundamental Rating

5

Overall CTVA gets a fundamental rating of 5 out of 10. We evaluated CTVA against 83 industry peers in the Chemicals industry. CTVA has an excellent profitability rating, but there are some minor concerns on its financial health. CTVA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • CTVA had positive earnings in the past year.
  • In the past year CTVA had a positive cash flow from operations.
  • CTVA had positive earnings in 4 of the past 5 years.
  • Of the past 5 years CTVA 4 years had a positive operating cash flow.
CTVA Yearly Net Income VS EBIT VS OCF VS FCFCTVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

  • CTVA has a better Return On Assets (3.80%) than 72.29% of its industry peers.
  • CTVA has a better Return On Equity (6.36%) than 68.67% of its industry peers.
  • With a decent Return On Invested Capital value of 5.99%, CTVA is doing good in the industry, outperforming 68.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CTVA is in line with the industry average of 6.09%.
  • The last Return On Invested Capital (5.99%) for CTVA is above the 3 year average (4.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.8%
ROE 6.36%
ROIC 5.99%
ROA(3y)2.21%
ROA(5y)2.47%
ROE(3y)3.76%
ROE(5y)4.19%
ROIC(3y)4.97%
ROIC(5y)3.98%
CTVA Yearly ROA, ROE, ROICCTVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6 -6

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.19%, CTVA belongs to the top of the industry, outperforming 84.34% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CTVA has declined.
  • CTVA has a Operating Margin of 14.96%. This is in the better half of the industry: CTVA outperforms 77.11% of its industry peers.
  • CTVA's Operating Margin has improved in the last couple of years.
  • CTVA has a better Gross Margin (46.11%) than 90.36% of its industry peers.
  • CTVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.96%
PM (TTM) 9.19%
GM 46.11%
OM growth 3Y13.79%
OM growth 5Y24.06%
PM growth 3Y-21.84%
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y2.77%
CTVA Yearly Profit, Operating, Gross MarginsCTVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

5

2. Health

2.1 Basic Checks

  • CTVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CTVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CTVA Yearly Shares OutstandingCTVA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CTVA Yearly Total Debt VS Total AssetsCTVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 2.61 indicates that CTVA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.61, CTVA is in the better half of the industry, outperforming 75.90% of the companies in the same industry.
  • CTVA has a debt to FCF ratio of 1.65. This is a very positive value and a sign of high solvency as it would only need 1.65 years to pay back of all of its debts.
  • CTVA's Debt to FCF ratio of 1.65 is amongst the best of the industry. CTVA outperforms 91.57% of its industry peers.
  • A Debt/Equity ratio of 0.14 indicates that CTVA is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.14, CTVA belongs to the best of the industry, outperforming 84.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.65
Altman-Z 2.61
ROIC/WACC0.39
WACC15.46%
CTVA Yearly LT Debt VS Equity VS FCFCTVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

  • CTVA has a Current Ratio of 1.58. This is a normal value and indicates that CTVA is financially healthy and should not expect problems in meeting its short term obligations.
  • CTVA has a Current ratio of 1.58. This is in the lower half of the industry: CTVA underperforms 66.27% of its industry peers.
  • CTVA has a Quick Ratio of 1.07. This is a normal value and indicates that CTVA is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.07, CTVA is not doing good in the industry: 60.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.07
CTVA Yearly Current Assets VS Current LiabilitesCTVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

3

3. Growth

3.1 Past

  • CTVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.20%, which is quite impressive.
  • CTVA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.22% yearly.
EPS 1Y (TTM)30.2%
EPS 3Y7.8%
EPS 5Y17.22%
EPS Q2Q%-31.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.71%

3.2 Future

  • Based on estimates for the next years, CTVA will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.91% on average per year.
  • Based on estimates for the next years, CTVA will show a small growth in Revenue. The Revenue will grow by 2.35% on average per year.
EPS Next Y12.4%
EPS Next 2Y12.45%
EPS Next 3Y11.44%
EPS Next 5Y8.91%
Revenue Next Year3.57%
Revenue Next 2Y3.34%
Revenue Next 3Y2.63%
Revenue Next 5Y2.35%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CTVA Yearly Revenue VS EstimatesCTVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B
CTVA Yearly EPS VS EstimatesCTVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 22.63, which indicates a rather expensive current valuation of CTVA.
  • The rest of the industry has a similar Price/Earnings ratio as CTVA.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, CTVA is valued at the same level.
  • The Price/Forward Earnings ratio is 20.13, which indicates a rather expensive current valuation of CTVA.
  • CTVA's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of CTVA to the average of the S&P500 Index (27.50), we can say CTVA is valued slightly cheaper.
Industry RankSector Rank
PE 22.63
Fwd PE 20.13
CTVA Price Earnings VS Forward Price EarningsCTVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CTVA.
  • 73.49% of the companies in the same industry are more expensive than CTVA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.13
EV/EBITDA 13.29
CTVA Per share dataCTVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CTVA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.82
PEG (5Y)1.31
EPS Next 2Y12.45%
EPS Next 3Y11.44%

4

5. Dividend

5.1 Amount

  • CTVA has a yearly dividend return of 0.98%, which is pretty low.
  • CTVA's Dividend Yield is comparable with the industry average which is at 2.26.
  • With a Dividend Yield of 0.98, CTVA pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

  • The dividend of CTVA is nicely growing with an annual growth rate of 30.66%!
  • CTVA has been paying a dividend for over 5 years, so it has already some track record.
  • As CTVA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)30.66%
Div Incr Years5
Div Non Decr Years5
CTVA Yearly Dividends per shareCTVA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • CTVA pays out 29.41% of its income as dividend. This is a sustainable payout ratio.
  • CTVA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP29.41%
EPS Next 2Y12.45%
EPS Next 3Y11.44%
CTVA Yearly Income VS Free CF VS DividendCTVA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
CTVA Dividend Payout.CTVA Dividend Payout, showing the Payout Ratio.CTVA Dividend Payout.PayoutRetained Earnings

CORTEVA INC

NYSE:CTVA (2/4/2026, 7:00:00 PM)

After market: 75.12 0 (0%)

75.12

+0.08 (+0.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-03
Earnings (Next)05-05
Inst Owners87.17%
Inst Owner Change-3.09%
Ins Owners0.07%
Ins Owner Change-0.69%
Market Cap50.76B
Revenue(TTM)N/A
Net Income(TTM)1.60B
Analysts80
Price Target80.02 (6.52%)
Short Float %1.86%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Yearly Dividend0.66
Dividend Growth(5Y)30.66%
DP29.41%
Div Incr Years5
Div Non Decr Years5
Ex-Date03-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.88%
Min EPS beat(2)14.15%
Max EPS beat(2)57.61%
EPS beat(4)4
Avg EPS beat(4)24.51%
Min EPS beat(4)0.21%
Max EPS beat(4)57.61%
EPS beat(8)7
Avg EPS beat(8)24.59%
EPS beat(12)10
Avg EPS beat(12)35.59%
EPS beat(16)13
Avg EPS beat(16)30.82%
Revenue beat(2)2
Avg Revenue beat(2)2.38%
Min Revenue beat(2)1%
Max Revenue beat(2)3.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)3.77%
Revenue beat(8)3
Avg Revenue beat(8)-3.19%
Revenue beat(12)4
Avg Revenue beat(12)-3.16%
Revenue beat(16)7
Avg Revenue beat(16)-2.07%
PT rev (1m)0.55%
PT rev (3m)-4.08%
EPS NQ rev (1m)0.51%
EPS NQ rev (3m)-29.59%
EPS NY rev (1m)0.24%
EPS NY rev (3m)5.78%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-1.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 22.63
Fwd PE 20.13
P/S 2.91
P/FCF 19.13
P/OCF 15.84
P/B 2.01
P/tB 8.08
EV/EBITDA 13.29
EPS(TTM)3.32
EY4.42%
EPS(NY)3.73
Fwd EY4.97%
FCF(TTM)3.93
FCFY5.23%
OCF(TTM)4.74
OCFY6.31%
SpS25.85
BVpS37.32
TBVpS9.29
PEG (NY)1.82
PEG (5Y)1.31
Graham Number52.8
Profitability
Industry RankSector Rank
ROA 3.8%
ROE 6.36%
ROCE 8.22%
ROIC 5.99%
ROICexc 6.49%
ROICexgc 16.71%
OM 14.96%
PM (TTM) 9.19%
GM 46.11%
FCFM 15.19%
ROA(3y)2.21%
ROA(5y)2.47%
ROE(3y)3.76%
ROE(5y)4.19%
ROIC(3y)4.97%
ROIC(5y)3.98%
ROICexc(3y)5.51%
ROICexc(5y)4.45%
ROICexgc(3y)17.68%
ROICexgc(5y)14.5%
ROCE(3y)6.47%
ROCE(5y)5.18%
ROICexgc growth 3Y17.34%
ROICexgc growth 5Y37%
ROICexc growth 3Y18.15%
ROICexc growth 5Y33.64%
OM growth 3Y13.79%
OM growth 5Y24.06%
PM growth 3Y-21.84%
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y2.77%
F-Score9
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.65
Debt/EBITDA 0.91
Cap/Depr 45.87%
Cap/Sales 3.15%
Interest Coverage 250
Cash Conversion 84.05%
Profit Quality 165.36%
Current Ratio 1.58
Quick Ratio 1.07
Altman-Z 2.61
F-Score9
WACC15.46%
ROIC/WACC0.39
Cap/Depr(3y)49.09%
Cap/Depr(5y)46.74%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.49%
Profit Quality(3y)117.89%
Profit Quality(5y)141.89%
High Growth Momentum
Growth
EPS 1Y (TTM)30.2%
EPS 3Y7.8%
EPS 5Y17.22%
EPS Q2Q%-31.25%
EPS Next Y12.4%
EPS Next 2Y12.45%
EPS Next 3Y11.44%
EPS Next 5Y8.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.71%
Revenue Next Year3.57%
Revenue Next 2Y3.34%
Revenue Next 3Y2.63%
Revenue Next 5Y2.35%
EBIT growth 1Y33.86%
EBIT growth 3Y16.75%
EBIT growth 5Y29.12%
EBIT Next Year58.29%
EBIT Next 3Y21.88%
EBIT Next 5Y13.88%
FCF growth 1Y1955.94%
FCF growth 3Y-10.43%
FCF growth 5YN/A
OCF growth 1Y673.91%
OCF growth 3Y-7.69%
OCF growth 5Y14.92%

CORTEVA INC / CTVA FAQ

What is the ChartMill fundamental rating of CORTEVA INC (CTVA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTVA.


What is the valuation status for CTVA stock?

ChartMill assigns a valuation rating of 3 / 10 to CORTEVA INC (CTVA). This can be considered as Overvalued.


How profitable is CORTEVA INC (CTVA) stock?

CORTEVA INC (CTVA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for CTVA stock?

The Price/Earnings (PE) ratio for CORTEVA INC (CTVA) is 22.63 and the Price/Book (PB) ratio is 2.01.


How financially healthy is CORTEVA INC?

The financial health rating of CORTEVA INC (CTVA) is 5 / 10.